With the Bitter Pill Awards, the Prescription Access Litigation Project highlights the transgressions of drug companies and PhARMA in the last year. Awards include the “overmarketing [of] insomnia medications to anyone who’s ever had a bad night’s sleep” and the publication of “toothless” drug advertising guidelines. They also have the “stranger than fiction” award for the PhARMA-commissioned bizarre novel based on the premise that drugs from Canada are tainted.
On a positive note, MedVantx was honored for “promoting safe, effective generics and countering drugs industry marketing.”
Read more about DTC drug advertising in this interesting article from PLoS Medicine.
[via Kevin, MD]
I agree with the Lunesta–does NOT work with me. But Ambien did get me thru a rough patch (and I would have sold my soul for some lately to get over my lyrica withdrawl!)